{"page":{"totalFilteredElements":38},"studies":[{"active":true,"description":"2- and 5-year neuropsychological follow-up of young\nchildren with medulloblastoma, CNS-PNET and ependymoma treated within the prospective\nmulticenter trial HIT 2000 SKK<br /><br />Geplante Laufzeit: 01.07.2013 - 31.03.2017<br />","eudractNumber":null,"id":964,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped3","name":"Hirntumore (Tumore des zentralen Nervensystems)"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_12","name":"N/A"},"recruitmentStart":"2013-07-01T13:26:27+02:00","shortTitle":"Neuropsychological diagnostics in HIT 2000 SKK","therapeutical":false,"therapyLines":[]},{"active":true,"description":"An International Clinical Program for the diagnosis and Treatment of children, adolescents and young adults with ependymoma","eudractNumber":"2013-002766-39","id":2398,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped3","name":"Hirntumore (Tumore des zentralen Nervensystems)"}],"mutations":[],"nctNumber":"NCT02265770","phase":{"id":"ph_8","name":"Phase II/III"},"recruitmentStart":"2020-06-18T10:07:43+02:00","shortTitle":"SIOP Ependymoma II","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"Eine internationale prospektive Studie zum klinischen Hochrisiko-Medulloblastom (HR-MB) bei Patienten, die &#228;lter als 3 Jahre sind","eudractNumber":"2018-004250-17","id":9623,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped3","name":"Hirntumore (Tumore des zentralen Nervensystems)"}],"mutations":[{"name":"TP53","id":"mt_24"},{"name":"MYC (c-MYC)","id":"mt_73"}],"nctNumber":null,"phase":{"id":"ph_9","name":"Phase III"},"recruitmentStart":"2024-04-19T10:36:51+02:00","shortTitle":"SIOP High-Risk Medulloblastoma","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"Internationale, prospektive \"Umbrella\" Studie incl. einer randomisierten Phase III-Studie zur Frage der Nichtunterlegenheit von 3 Kursen Hochdosis-Chemotherapie verglichen mit fokaler Radiotherapie + Standard-Chemotherapie in der Konsolidierung nach einer konventionellen Induktions-Chemotherapie f&#252;r Kinder mit einem ATRT im Alter von 12 - 35 Monaten zum Zeitpunkt der Bestrahlung","eudractNumber":"2018-003335-29","id":4960,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped3","name":"Hirntumore (Tumore des zentralen Nervensystems)"}],"mutations":[{"name":"Others","id":"mt_8"}],"nctNumber":null,"phase":{"id":"ph_9","name":"Phase III"},"recruitmentStart":"2021-07-22T13:46:52+02:00","shortTitle":"SIOPe ATRT-01","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"Seltene Tumorerkrankungen in der P&#228;diatrie. STEP. Registry of the German Society for Pediatric Oncologie and Hematology (GPOH).<br />","eudractNumber":null,"id":967,"indications":[{"id":"sar","name":"Sarkome"},{"id":"sar1","name":"Knochensarkome (Ewing-Sarkom, Osteosarkom etc.)"},{"id":"sar2","name":"Weichteilsarkome (Liposarkom, Leiomyosarkom, etc.)"},{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2008-11-05T09:42:08+01:00","shortTitle":"STEP","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"Register f&#252;r Weichteilsarkome (engl. Soft tissue Sarcoma; STS) und andere Weichteiltumore bei Kindern, Jugendlichen und jungen Erwachsenen.","eudractNumber":null,"id":12045,"indications":[{"id":"sar","name":"Sarkome"},{"id":"sar1","name":"Knochensarkome (Ewing-Sarkom, Osteosarkom etc.)"},{"id":"sar2","name":"Weichteilsarkome (Liposarkom, Leiomyosarkom, etc.)"},{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2026-06-12T09:36:56+02:00","shortTitle":"SoTiSaR 2.0-NIS","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"<div>INTERNATIONAL EURO EWING TRIAL FOR TREATMENT OPTIMISATION IN PATIENTS WITH EWING SARCOMA</div>","eudractNumber":"2019-004153-93","id":9005,"indications":[{"id":"sar","name":"Sarkome"},{"id":"sar1","name":"Knochensarkome (Ewing-Sarkom, Osteosarkom etc.)"},{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_9","name":"Phase III"},"recruitmentStart":"2023-12-04T12:22:30+01:00","shortTitle":"i EuroEwing","therapeutical":true,"therapyLines":[{"id":"tl_3","name":"Drittlinie"}]},{"active":true,"description":"International Registry of the HIT-HGG Study Group for Paediatric Patients and Young Adults with High Grade Gliomas","eudractNumber":null,"id":10796,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped3","name":"Hirntumore (Tumore des zentralen Nervensystems)"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2023-01-01T14:06:32+01:00","shortTitle":"iHIT-HGG Registry","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]}]}